Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Icon link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.


The FDA is rethinking the timing of pediatric clinical trials

Historically, pediatric atopic dermatitis patients have been excluded from the early stages of the drug development process, but this soon may change.

Read More

Study finds increased risk of cardiovascular disease for people with atopic dermatitis

A large-scale study conducted in the United Kingdom concluded that people with severe atopic dermatitis may be at an increased risk for cardiovascular disease.

Read More

Researchers identify link between atopic dermatitis and suicidal thoughts, behavior

Research studies reveal that people with atopic dermatitis are more likely to harbor suicidal thoughts than those without the disease.

Read More

It’s time for our annual treatment roundup

In the “Golden Age of Eczema,” people with atopic dermatitis have more treatment options than ever before, with even more drugs making their way to pharmacy shelves.

Read More

Eczema infants face double whammy of related health conditions

Research reveals children with atopic dermatitis under age 2 are at greater risk for asthma and allergies.

Read More

Can probiotics help kids with atopic dermatitis?

New evidence shows that Lactobacillus-containing probiotic strains may reduce disease severity in children age 3 and under.

Read More

Low-dose Naltrexone for atopic dermatitis?

Dermatologists discuss the potential efficacy of prescribing an opioid antagonist to address the problem of itch in atopic dermatitis.

Read More

AD topical cream Jakafi moving on to phase 3 clinical trial

A new, nonsteroidal topical cream for AD called Jakafi (ruxolitinib) may soon hit pharmacy shelves.

Read More

New biomarkers identified for pediatric AD

Does atopic dermatitis behave differently based on a person’s skin tone? Researchers at the University of Amsterdam are trying to find out.

Read More

Biologics may show greater risk for infection than systemics

Off-label use of biologic treatments for atopic dermatitis may double the risk for serious infection compared to systemic treatments, researchers found.

Read More